Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;63(2):140-149.
doi: 10.1007/s12033-020-00290-8. Epub 2021 Jan 2.

Necessity for Validation of Effectiveness of Selected Guide RNA In Silico for Application of CRISPR/Cas9

Affiliations

Necessity for Validation of Effectiveness of Selected Guide RNA In Silico for Application of CRISPR/Cas9

Dong-Hwan Kim et al. Mol Biotechnol. 2021 Feb.

Abstract

Selection of guide RNA (gRNA) is important to increase the efficiency of gene editing in the CRISPR/Cas9 system. Due to the variation in actual efficiency of insertion/deletion (indel) mutation among selected gRNAs in silico, reliable methods for validation of efficiency of gRNA need to be developed. Three gRNAs with high on-target scores (72.0 for target 1, 65.4 for target 2, and 62.9 for target 3) were designed to target the quail retinol binding protein 7 (qRbp7) gene, and indel efficiencies were predicted by the Sanger sequencing and Inference of CRISPR Edits (ICE) analysis of sorted cell populations receiving the CRISPR/Cas9 vector. Unlike the order of on-target scores among 3 gRNAs, predicted rates of indel mutations were highest in gRNA2, intermediate in gRNA1, and lowest in gRNA3. This was confirmed by actual indel mutation rates, 51.8% in gRNA2, 31% in gRNA1, and 12.9% in gRNA3, which were calculated by sequencing individual allele cloned into a vector. These data showed a rapid and reliable method for estimation of the efficiency of selected gRNAs, providing a critical necessary step for successful gene editing for further applications.

Keywords: CRISPR/Cas9; Gene editing; Guide RNA; Quail cells; Sequencing; Validation.

PubMed Disclaimer

References

    1. Bhaya, D., Davison, M., & Barrangou, R. (2011). CRISPR-Cas systems in bacteria and archaea: Versatile small RNAs for adaptive defense and regulation. Annual Review of Genetics, 45(1), 273–297. https://doi.org/10.1146/annurev-genet-110410-132430 . - DOI - PubMed
    1. Wong, N., Liu, W., & Wang, X. (2015). WU-CRISPR: Characteristics of functional guide RNAs for the CRISPR/Cas9 system. Genome Biology, 16(1), 1–8. https://doi.org/10.1186/s13059-015-0784-0 . - DOI
    1. Tasan, I., & Zhao, H. (2017). Targeting specificity of the CRISPR/Cas9 system. ACS Synthetic Biology, 6(9), 1609–1613. https://doi.org/10.1021/acssynbio.7b00270 . - DOI - PubMed
    1. Briner, A. E., Donohoue, P. D., Gomaa, A. A., Selle, K., Slorach, E. M., Nye, C. H., et al. (2014). Guide RNA functional modules direct Cas9 activity and orthogonality. Molecular Cell, 56(2), 333–339. https://doi.org/10.1016/j.molcel.2014.09.019 . - DOI - PubMed
    1. Hung, S. S. C., McCaughey, T., Swann, O., Pébay, A., & Hewitt, A. W. (2016). Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease. Progress in Retinal and Eye Research. https://doi.org/10.1016/j.preteyeres.2016.05.001 . - DOI - PubMed

Publication types

Substances

LinkOut - more resources